Activation of p53 by Nutlin-3a, an antagonist of MDM2, induces apoptosis and cellular senescence in adult T-cell leukemia cells (Q39807622)

14 September 2017

title

Activation of p53 by Nutlin-3a, an antagonist of MDM2, induces apoptosis and cellular senescence in adult T-cell leukemia cells (English)

1 reference

14 September 2017

0 references

1 reference

1 reference

1 reference

H Iha

3

0 references

author name string

H Hasegawa

1

1 reference

14 September 2017

Y Yamada

2

1 reference

14 September 2017

K Tsukasaki

4

1 reference

14 September 2017

K Nagai

5

1 reference

14 September 2017

S Atogami

6

1 reference

14 September 2017

K Sugahara

7

1 reference

14 September 2017

K Tsuruda

8

1 reference

14 September 2017

A Ishizaki

9

1 reference

14 September 2017

S Kamihira

10

1 reference

14 September 2017

publication date

27 August 2009

1 reference

14 September 2017

1 reference

14 September 2017

volume

23

1 reference

14 September 2017

issue

11

1 reference

14 September 2017

page(s)

2090-2101

1 reference

https://scigraph.springernature.com/pub.10.1038/leu.2009.171

14 September 2017

exact match

0 references

cites work

Coping with stress: multiple ways to activate p53.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.171

p53 modulation of the DNA damage response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.171

Dissecting p53-dependent apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.171

The P53 pathway: what questions remain to be explored?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.171

The transcriptional targets of p53 in apoptosis control

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.171

TIGAR, a p53-inducible regulator of glycolysis and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.171

Hzf, a p53-responsive gene, regulates maintenance of the G2 phase checkpoint induced by DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.171

Hzf Determines cell survival upon genotoxic stress by modulating p53 transactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.171

Cellular senescence in cancer and aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.171

The regulation of INK4/ARF in cancer and aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.171

Discovery of HTLV-1, the first human retrovirus, its unique regulatory mechanisms, and insights into pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.171

Natural history of adult T-cell leukemia/lymphoma and approaches to therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.171

The current status of therapy for adult T-cell leukaemia-lymphoma in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.171

Molecular mechanisms of cellular transformation by HTLV-1 Tax.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.171

Impact of HTLV-I Tax on cell cycle progression and the cellular DNA damage repair response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.171

Aberrant expression and function of p53 in T-cells immortalized by HTLV-I Tax1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.171

Evidence for NF-kappaB- and CBP-independent repression of p53's transcriptional activity by human T-cell leukemia virus type 1 Tax in mouse embryo and primary human fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.171

Shaping genetic alterations in human cancer: the p53 mutation paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.171

In vivo activation of the p53 pathway by small-molecule antagonists of MDM2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.171

MDM2 inhibitors for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.171

Sensitivity of adult T-cell leukaemia lymphoma cells to tumour necrosis factor-related apoptosis-inducing ligand.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.171

Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.171

Natural antibodies to the human T cell lymphoma virus in patients with cutaneous T cell lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.171

Characteristic expression of HTLV-1 basic zipper factor (HBZ) transcripts in HTLV-1 provirus-positive cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.171

A Method for Testing for Synergy with Any Number of Agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.171

A novel natural compound, a cycloanthranilylproline derivative (Fuligocandin B), sensitizes leukemia cells to apoptosis induced by tumor necrosis factor related apoptosis-inducing ligand (TRAIL) through 15-deoxy-Delta 12, 14 prostaglandin J2 product

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.171

Segregation of NF-kappaB activation through NEMO/IKKgamma by Tax and TNFalpha: implications for stimulus-specific interruption of oncogenic signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.171

Frequent mutations in the p53 tumor suppressor gene in human leukemia T-cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.171

p53 mutations in human lymphoid malignancies: association with Burkitt lymphoma and chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.171

MDM2 antagonists induce p53-dependent apoptosis in AML: implications for leukemia therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.171

MDM2 antagonists activate p53 and synergize with genotoxic drugs in B-cell chronic lymphocytic leukemia cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.171

Dihydroflavonol BB-1, an extract of natural plant Blumea balsamifera, abrogates TRAIL resistance in leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.171

Modeling the therapeutic efficacy of p53 restoration in tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.171

Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.171

Restoration of p53 function leads to tumour regression in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.171

Small-molecule MDM2 antagonists reveal aberrant p53 signaling in cancer: implications for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.171

Small-molecule MDM2 antagonists as a new therapy concept for neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.171

Divorcing ARF and p53: an unsettled case

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.171

Tumour biology: senescence in premalignant tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.171

Persistent inhibition of telomerase reprograms adult T-cell leukemia to p53-dependent senescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.171

Inhibition of methyltransferases results in induction of g2/m checkpoint and programmed cell death in human T-lymphotropic virus type 1-transformed cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.171

PI3K/AKT inhibition induces caspase-dependent apoptosis in HTLV-1-transformed cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.171

Small-molecule inhibitor which reactivates p53 in human T-cell leukemia virus type 1-transformed cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.171

Activation of the anaphase promoting complex by HTLV-1 tax leads to senescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.171

Mdm2 is critically and continuously required to suppress lethal p53 activity in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.171

The clinical trail of TRAIL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.171

TRAIL: a multifunctional cytokine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.171

p16 and ARF: activation of teenage proteins in old age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.171

inferred from DOI database lookup

7 January 2021

based on heuristic

Impact of p53 aberration on the progression of Adult T-cell Leukemia/Lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.171

inferred from DOI database lookup

7 January 2021

based on heuristic

Adult T-cell leukemia: structures and expression of the p53 gene

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.171

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/LEU.2009.171

1 reference

14 September 2017

1 reference